¼±¹Èñ ±³¼ö
ÇзÂ
1985¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Çлç 1995¼¿ï´ëÇб³ ´ëÇпø ÀÇÇÐ ¼®»ç 1999¼¿ï´ëÇб³ ´ëÇпø ÀÇÇÐ ¹Ú»ç |
°æ·Â
~ 1996¼¿ï´ëÇб³º´¿ø ¼ö·Ã ¹× Àü°øÀÇ ¼ö·á 2015 ~ 2017ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø Á¤½Å°Ç°ÀÇÇаú °úÀå 2012 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø Á¤½Å°Ç°ÀÇÇаú ±³¼ö |
¼ö»óÀÌ·Â
º¸°Ç»çȸºÎÀå°ü»ó ¼ö»ó |
³í¹®/Àú¼
´ëÇ¥ ³í¹® ¹× Àú¼ 1. ³ëÀÎÁ¤½ÅÀÇÇÐ °³Á¤ÆÇ-´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸÆí (°øÀú, 2004) 2. ¸ÓÅ© ¸Å´º¾ó ³ëÀκ´ÇÐ. (°ø¿ª, 2003) 3. CARDS manual (2003) 4. Á¤½ÅÀå¾ÖÀÇ ÀÌÇØ (1997) ¿Ü Àú¼ 7±Ç°ú Çмú³í¹® 52Æí(±¹Á¦ 24/±¹³» 28) 5. Çѱ¹ Àα¸ÀÇ ³ë·ÉÈ¿Í Ä¡¸Å: Àå·¡ Ãß°è¿Í Àü¸Á.(02) 6. Dementia in Korea: Trend and Projection(02) 7.Diagnostic Capability of the Cognitive Assessment and Reference Diagnoses System(CARDS).(02) 8. Ageing in Korean population and Dementia:Future projection and Perspective.(02) 9. Çѱ¹¾îÆÇ ³ëÀÎÁ¤½Å»óÅ°˻ç(GMS-AGECAT)ÀÇ ½Å·Úµµ ¹× Ÿ´çµµ.(02, °øÀú) 10. Dementia in an Aging and Aged Society.(02) 11. Ä¡¸Å-ÀÏÂï ¾Ë°í ¹à°Ô »ìÀÚ.(02) 12. ¸ÓÅ©¸Þ´º¾ó ³ëÀκ´ÇÐ Çѱ¹¾î ÃÊÆÇ.(03) 13. CARDS manual for neuropsychological and clinical examination for clinical and population use.(03) 14. Community study of Dementia in the Older Korean population : Inference to Epidemiological Transition in Dementia.(03, °øÀú) 15. Cognitive Assessment & Reference Diagnosis System (CARDS): the development of a neuropsychological and clinical examination for clinic and population use.(03, °øÀú) 16. Psychogeriatrics in Korea.(03) 17. Ä¡¸Å ±â´ÉÆò°¡¸¦ À§ÇÑ Ä¡¸ÅÀå¾ÖÆò°¡Ã´µµ Çѱ¹¾îÆÇ(DAD-K)ÀÇ °³¹ß.(03) 18. Ä¡¸Å ÀÎÁöÆò°¡¸¦ À§ÇÑ ¾ËÂêÇÏÀ̸Ӻ´Æò°¡Ã´µµ Çѱ¹¾îÆÇ(ADAS-K)ÀÇ °³¹ß.(03) 19. ¸®½ºÆ丮µ·°ú ¿Ã¶õÀÚÇÉÀÇ ÈÄÇâÀû ºñ±³ ¾à¹°°æÁ¦ÇÐÀû ¿¬±¸.(03, °øÀú) 20. Ä¡¸Å Áø´ÜÀ» À§ÇÑ °³Á¤ Ä·ºê¸®Áö ÀÎÁö°Ë»ç(CAMCOG-R) Çѱ¹¾îÆÇÀÇ Ç¥ÁØÈ.(03, °øÀú) 21. Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimers Disease in a Korean Population: A 52-Week Prospective Study.(08, °øÀú) 22. A prospective, Double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate AD in a Korean population.(04, °øÀú) 23. Agitated behaviours among the institutionalized elderly with dementia: Validation of the Korean version of the Cohen-Mansfield agitation inventory.(04) 24. Effect of antipsychotics on mortality in the elderly with dementia: A 1-year prospective study in a nursing home(05, °øÀú) 25. [Book Review] Assessment scales in old age psychiatry, 2nd Ed.(05) 26. Mortality in Alzheimer¡¯s disease. A comparative prospective Korean study in community and nursing home(05, °øÀú) 27. Mental health care in South Korea(05, °øÀú) 28. A community study of depression in old age.(05) 29. Comparative efficacy of risperidone versus haloperidol on BPSD(06, °øÀú) 30. Validation of the SIB for patients with AD in Korea(06, °øÀú) 31. The Economic costs of dementia in Korea, 2002(06, °øÀú) 32. Predictors of Mortality in an Aging Community-Based Cohort in Korea(06) 33 .Effect of the Apolipoprotein E4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer¡¯s disease(06, °øÀú) 34. ³ëÀκ´ ¾à¹°¿ä¹ý(06, °øÀú)/Drug therapy in Geriatrics 35. °³Á¤ Ä·ºê¸®Áö ³ëÀÎÁ¤½ÅÀå¾Ö°Ë»ç CAMDEX-R(06) 36. The economic costs of dementia in Korea.(06, °øÀú) 37. Predictors of Mortality in an Aging Community-Based Cohort in Korea.(06) 38. Eldery dementia in Korea.(07) 39. Drug therapy for Alzheimers Disease(07) 40. Mental health economics, health service provision, and the practice of geriatric psychiatry(08, °øÀú) 41. ºñ¼¾çÀÇ °üÁ¡À¸·Î ¼¾ç º¸±â: °³ÀÎÁß½ÉÀû ȤÀº »çȸÁß½ÉÀû?(08)/Looking at the West from the non-West: egocentric or sociocentric? 42. Ä¡¸Å¿¡ ´ëÇÑ Ç×Á¤½Åº´¾à¹°ÀÇ »ç¿ë : Simpson paradox¸¦ »ó±âÇØ¾ß ÇÑ´Ù.(09)/Use of antypical antipsychotics for dementia : Rethinking Simpson¡¯s paradox |